Westmead Dermatology
Striving towards disease-free skin
Written by Dr Shelley Hwang Diphencyprone (DPCP) is a topical immunotherapy that is often used to treat alopecia areata and warts. However, there has been some case studies describing its efficacy in treating in-transit melanoma tumours that are not suitable for neither surgery or radiotherapy. We have incorporated Royal Prince Alfred hospital’s DPCP protocol to …
Written by Dr Shelley Hwang Recently, we have published a review article describing “Cutaneous adverse events of new anti-melanoma therapies: classification and management” in Actas Dermo-sifiliograficas. The review article describes comprehensive summary of cutaneous adverse events that emerge with the use of systemic anti-melanoma therapies such as BRAF inhibitors, MEK inhibitors, a combination of BRAF …
Written by Ali Azimi Recently, our original research paper titled “In Silico Analysis Validates Proteomic Findings of Formalin-fixed Paraffin Embedded Cutaneous Squamous Cell Carcinoma Tissue” has been accepted for publication in the journal of Cancer Genomics & Proteomics (CGP). The manuscript will be published in the next available issue of CGP. CGP is an international …
During Westmead Hospital Week, the Department of Dermatology participated in the Melanoma Symposium. We presented our High Risk Melanoma Clinic, and the technologies that we are using to increase our sensitivity and specificity in detecting melanomas, and reduce the number of unnecessary surgeries: Total Body Photography, Sequential Digital Dermoscopy, and, very soon, Reflectance Confocal Microscopy. …
The Skin Hospital, a branch of the Skin and Cancer Foundation Australia, is the biggest provider of Mohs surgery in Australia. This is a very specialised technique to treat skin cancer that minimised the removal of healthy skin and increases the chances of complete clearance. At the Skin and Cancer Foundation Australia we are interesting …
Written by Dr Shelley Ji Eun Hwang Recently, we have successfully held ‘Melanoma Monday in May’ education forum for the general public at Westmead hospital auditorium on 23rd of May. This forum was aimed at educating patients and their families from the diagnosis and treatment of melanoma. The first speaker was Professor Mann (geneticist) who …
Written by Dr Shelley Ji Eun Hwang We will be holding “Melanoma Monday in May” education session at Westmead auditorium on 23rd of May 2016. The session aims to increase the awareness of melanoma to the general public and to educate on the preventative measures, diagnosis and treatment options. Informative talks will be provided by …
The 21st Annual Lorne Proteomics Symposium, organized by the Australasian Proteomics Society, was held between February 4th – 7th 2016 at the Mantra hotel and conference centre in Lorne, Victoria. The Symposium which was attended by more than a hundred scientists and researchers presented the latest developments in proteomics technologies and tools for the interpretation …
The JAAD has recently published our paper describing the cutaneous immune-related adverse events (irAE) that appear with anti-PD1 monoclonal antibodies (pembrolizumab or nivolumab). These molecules do not create the dramatic changes in melanoma metastasis that BRAF inhibitors show, but it seems to create more sustained responses. Moreover, they are the most effective treatment for patients …
The 11th EADO Congress and 8th World Meeting of Interdisciplinary Melanoma/Skin Cancer Center was held from 28 to 31st of Oct 2015 in Marseille, France. I was fortunate to attend the conference in the beautiful city of Marseille and enjoy a very informative scientific program. The following 3 posters were presented from our team: 1. …
